Ferrlecit and Sleep disorder - a phase IV clinical study of FDA data

Summary:

Sleep disorder is reported as a side effect among people who take Ferrlecit (sodium ferric gluconate complex), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Neuralgia.

The phase IV clinical study analyzes which people have Sleep disorder when taking Ferrlecit. It is created by eHealthMe based on reports of 2,367 people who have side effects when taking Ferrlecit from the FDA, and is updated regularly.

What is Ferrlecit?

Ferrlecit has active ingredients of sodium ferric gluconate complex. eHealthMe is studying from 2,376 Ferrlecit users. Check the latest studies of Ferrlecit.

What is Sleep disorder?

Sleep disorder is found to be associated with 2,107 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Sleep disorder.

On Jul, 08, 2026

2,367 people reported to have side effects when taking Ferrlecit.
Among them, 39 people (1.65%) have Sleep disorder.

Among these 39 people:

How long have people been on Ferrlecit when they have Sleep disorder? *

What is the gender of people who have Sleep disorder when taking Ferrlecit? *

female: 2.7 %
male: 97.3 %

What is the age of people who have Sleep disorder when taking Ferrlecit? *

What are other drugs people take besides Ferrlecit? *

What are other side effects people have besides Sleep disorder? *

Neuralgia (pain in one or more nerves): 35 people, 89.74%
Dyspnea (difficult or laboured breathing): 35 people, 89.74%
Swelling: 35 people, 89.74%
Abdominal Distension: 34 people, 87.18%
Thrombosis (formation of a blood clot inside a blood vessel): 34 people, 87.18%
Nausea (feeling of having an urge to vomit): 34 people, 87.18%
Ascites (accumulation of fluid in the abdominal cavity): 34 people, 87.18%
Drowsiness: 34 people, 87.18%
Nausea And Vomiting: 34 people, 87.18%
Dry Mouth: 34 people, 87.18%

What are the existing conditions these people have? *

Anaemia (lack of blood): 38 people, 97.44%
Diabetes: 38 people, 97.44%
Constipation: 38 people, 97.44%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 38 people, 97.44%
High Blood Cholesterol: 38 people, 97.44%
Ventricular Fibrillation (abnormally irregular heart rhythm): 38 people, 97.44%
Iron Deficiency: 38 people, 97.44%
Blood Uric Acid Increased: 38 people, 97.44%
Nausea And Vomiting: 38 people, 97.44%
Neuralgia (pain in one or more nerves): 38 people, 97.44%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrlecit and have Sleep disorder?

- Check whether Sleep disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ferrlecit:

Ferrlecit (2,376 reports)

Sleep disorder treatments and more:

Sleep disorder (167,338 reports)

How severe was Sleep disorder and when was it recovered:

Sleep disorder in Ferrlecit

Expand to all the drugs that have ingredients of sodium ferric gluconate complex:

Sleep disorder and drugs with ingredients of sodium ferric gluconate complex

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ferrlecit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sleep disorder:

Sleep disorder (2,107 drugs)

Browse all the conditions that are associated with Sleep disorder:

Sleep disorder (2,938 conditions)

Related publications that referenced our studies

Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on sodium ferric gluconate complex (the active ingredients of Ferrlecit) and Ferrlecit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.